OTC Healthcare in Kenya
Euromonitor International's OTC Healthcare in Kenya market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 92 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
OTC Healthcare maintains steady growth despite political crisis in early 2008
In 2008 OTC Healthcare maintained steady retail value growth despite a poor start early in the year due to post election violence when many businesses temporarily ceased trading, many business premises were looted and transportation was halted, which thus led to a slow down in retail value sales over the first quarter of the year. However, the situation changed once a governmental coalition was formed, resulting in peace and thus enabling retailers to commence trading. By the end of 2008 the majority of companies affected had recovered their losses.
Companies affected by rising cost of production
In addition to the high cost of raw materials, rising inflation and the high cost of fuel led to increases in production costs for manufacturers in OTC Healthcare in 2008. Most companies considered importing medicinal products from other countries in order to reduce their operational costs. In some cases, for example Reckitt Benckiser East Africa Ltd, the high cost of production prompted companies to cease their manufacturing operations in Kenya.
GlaxoSmithKline East Africa Ltd continues to lead in OTC Healthcare
GlaxoSmithKline East Africa Ltd continued to lead in OTC Healthcare in Kenya in 2008. The company benefits from its long-standing presence in Kenya and it relies on its loyal consumer base. The increase in inflation, fuel costs, electricity and cost of labour prompted the company to increase its product pricing in 2008, nevertheless, despite the high cost of many of its products, the company maintained its lead while other players attempted to catch up.
Chemists/pharmacies remains leading distribution channel
Despite a slight decrease in its retail value share due to post election violence, chemists/pharmacies continued to be the leading channel of distribution for OTC Healthcare in 2008. Almost all channels of distribution were affected by the post election violence that occurred in Kenya during the first quarter of 2008, as a result of which there were no major changes in distribution trends in OTC Healthcare in 2008. Furthermore, chemists/pharmacies retailers offer a wider variety of products than retailers in other channels.
Inflation and production costs expected to increase over forecast period
OTC Healthcare is expected to experience a slow down over the forecast period, which is expected to be attributable to further increases in inflation and also production costs, which in turn will hamper volume demand. The cost of raw materials increased over the review period and is expected to increase further over the forecast period as a result of which more companies are expected to potentially cease production activities in Kenya.
Table of contents
OTC HEALTHCARE IN KENYA : MARKET INSIGHT
EXECUTIVE SUMMARY
OTC Healthcare maintains steady growth despite political crisis in early 2008
Companies affected by rising cost of production
GlaxoSmithKline East Africa Ltd continues to lead in OTC Healthcare
Chemists/pharmacies remains leading distribution channel
Inflation and production costs expected to increase over forecast period
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Regulation
De-listing or de-reimbursement
Advertising
Packaging
Labelling
Distribution
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
DEFINITIONS
Summary 1 Research Sources
ANALGESICS
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Analgesics Company Shares by Value 2004-2008
Table 15 Analgesics Brand Shares by Value 2005-2008
Table 16 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 17 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 20 Sales of Decongestants by Type: Value 2003-2008
Table 21 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 22 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 24 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 25 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 27 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 29 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 30 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 31 Herbal vs Standard Digestive Remedies 2003-2008
Table 32 Digestive Remedies Company Shares by Value 2004-2008
Table 33 Digestive Remedies Brand Shares by Value 2005-2008
Table 34 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 35 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE
Headlines
Trends
Switches
Competitive Landscape
Prospects
Sector Data
Table 36 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 37 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 38 Herbal vs Standard Medicated Skin Care 2003-2008
Table 39 Medicated Skin Care Company Shares by Value 2004-2008
Table 40 Medicated Skin Care Brand Shares by Value 2005-2008
Table 41 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 42 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 43 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN KENYA
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 44 Dietary Supplements: Brand Ranking by Positioning 2008
Table 45 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 46 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 47 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 48 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 49 Vitamins Brand Shares by Value 2005-2008
Table 50 Dietary Supplements Brand Shares by Value 2005-2008
Table 51 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 52 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS
Headlines
EYE CARE
Headlines
Sector Data
Table 53 Sales of Eye Care by Subsector: Value 2003-2008
Table 54 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 55 Eye Care Company Shares by Value 2004-2008
Table 56 Eye Care Brand Shares by Value 2005-2008
Table 57 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 58 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
WOUND TREATMENTS
Headlines
Sector Data
Table 59 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 60 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 61 Wound Treatments Company Shares by Value 2004-2008
Table 62 Wound Treatments Brand Shares by Value 2005-2008
Table 63 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 64 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
EAR CARE
Headlines
Sector Data
Table 65 Sales of Ear Care: Value 2003-2008
Table 66 Sales of Ear Care: % Value Growth 2003-2008
Table 67 Ear Care Company Shares by Value 2004-2008
Table 68 Ear Care Brand Shares by Value 2005-2008
Table 69 Forecast Sales of Ear Care: Value 2008-2013
Table 70 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE
Headlines
Sector Data
Table 71 Sales of Adult Mouth Care: Value 2003-2008
Table 72 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 73 Adult Mouth Care Company Shares by Value 2004-2008
Table 74 Adult Mouth Care Brand Shares by Value 2005-2008
Table 75 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 76 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS
Headlines
Sector Data
Table 77 Sales of Calming and Sleeping Products: Value 2003-2008
Table 78 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 79 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 80 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 81 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 82 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
EMERGENCY CONTRACEPTION
Headlines
Sector Data
Table 83 Sales of Emergency Contraception: Value 2003-2008
Table 84 Sales of Emergency Contraception: % Value Growth 2003-2008
Table 85 Emergency Contraception Company Shares by Value 2004-2008
Table 86 Emergency Contraception Brand Shares by Value 2005-2008
Table 87 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 88 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013
BIODEAL LABORATORIES LTD
Strategic Direction
Key Facts
Summary 2 Biodeal Laboratories Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 3 Biodeal Laboratories Ltd: Competitive Position 2008
OMAERA PHARMACEUTICALS LTD
Strategic Direction
Key Facts
Summary 4 Omaera Pharmaceuticals Ltd: Key Facts
Company Background
Production
Competitive Positioning